Business & Consumer Services » Business Services | Interpace Diagnostics Group Inc.

Interpace Diagnostics Group Inc. | Ownership

Companies that own Interpace Diagnostics Group Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
BlackRock Fund Advisors
1,158,352
4.11%
0
0%
06/30/2018
Sabby Capital LLC
932,954
3.31%
13,100
0.67%
06/30/2018
The Vanguard Group, Inc.
865,972
3.07%
113,502
0%
06/30/2018
Schonfeld Strategic Advisors LLC
225,000
0.8%
225,000
0.02%
06/30/2018
Geode Capital Management LLC
135,723
0.48%
50,728
0%
06/30/2018
WealthSource Partners LLC
48,000
0.17%
48,000
0.02%
06/30/2018
Northern Trust Investments, Inc.
26,258
0.09%
0
0%
06/30/2018
Citadel Advisors LLC
26,177
0.09%
26,177
0%
06/30/2018
Cambridge Investment Research Advisors, Inc.
22,610
0.08%
10
0%
06/30/2018
Raymond James & Associates, Inc. (Invt Mgmt)
20,000
0.07%
0
0%
06/30/2018

About Interpace Diagnostics Group

View Profile
Address
Morris Corporate Center 1
Parsippany New Jersey 07054
United States
Employees -
Website http://www.interpacediagnostics.com
Updated 07/08/2019
Interpace Diagnostics Group, Inc. is an bioinformatics company, which engages in the development and commercialization of molecular diagnostic test and pathology services. It offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion molecular test that can aid in pancreatic cyst diagnosis and pancreatic cancer risk assessment; ThyGenX and PathFinderTG which assesses thyroid nodules for risk of malignancy; and ThyraMIR, which assesses thyroid nodules for risk of malignancy utilizing a proprietary gene expression assay. The company was founded by John P.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.